Formulation of Monoclonal Antibody Therapies

His research is on the areas of formulation of macromolecules, solid dosage forms, gene therapy, niosomal nano-particulate systems and enhancement of dissolution of poorly-water soluble drugs and has received several awards and presented work at several national and international conferences. Research outcomes are reachable to non-specialist audiences as well as to experts in the field of pharmaceutics and are recognised both nationally and internationally as evidenced from the significantly publish of over 130 publications, including journal articles and conference papers, most of which are published in high-impact journals and well-cited. Dr Elkordy has extensive teaching experience incorporating research findings as “Research informs Teaching”. He designed MSc Pharmaceutical and BioPharmaceutical Formulations which is one of the few courses in the UK covering biopharmaceuticals as well as pharmaceuticals.

1. Introduction about monoclonal antibodies
2. Biosimilar antibodies
3. Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies
4. Route of monoclonal antibodies administration
5. Industrial aspects of finished monoclonal antibody therapies
6. Application of approved and marketed products of monoclonal antibody therapies